Variant Outcomes of Liver Transplantation for Hepatitis C Virus Patients in Different Age Categories: Impact of the Model for End-Stage Liver Disease Score

Zhenhua Hu,Jie Zhou,Zhiwei Li,Jie Xiang,Qijun Zhang,Sheng Yan,Jian Wu,Min Zhang,Weilin Wang,Shusen Zheng
DOI: https://doi.org/10.1002/jhbp.435
2017-01-01
Journal of Hepato-Biliary-Pancreatic Sciences
Abstract:BackgroundWhether the introduction of model for end-stage liver disease (MELD) has an effect on transplant outcome for different age categories remain unclear.MethodsWe analyzed 49,762 adult hepatitis C virus (HCV) candidates through 1 January 1995 to 31 December 2012 from the Scientific Registry of Transplant Recipients. Patients were divided into four age categories (18-34, 35-49, 60-64, 65 years) in the pre-MELD era and MELD era, respectively.ResultsWaiting list dropouts have decreased in the MELD era for all categories. A reduced trend in survival was observed for 18-34 years patients in the MELD era compared with the pre-MELD era, with 5-year intention-to-treat, overall and graft survival of 56.5%, 57.9%, 56.3% vs. 56.4%, 69.7%, 64.4% (P = 0.604, 0.034, and 0.071, respectively). For other age categories, survival rates were all superior in the MELD era. Cox-regression analysis showed values of hazard ratio for age increased with advanced age (all >1) in the pre-MELD era compared with the reference group (18-34 years), while these hazard ratios were <1 for overall and graft survival in MELD era.ConclusionsOur study provides useful evidence that the introduction of MELD for liver allocation may adversely affect survival of specific HCV patients.
What problem does this paper attempt to address?